European Archives - Page 364 of 1636 - European Medical Journal

vitiligo

Does Facial Vitiligo Increase Social Anxiety?

Social appearance anxiety was strongly linked to higher general anxiety, depressive symptoms, and reduced quality of life.

Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists

Glucagon-like peptide-1 receptor agonists (GLP-1RA) are widely prescribed for Type 2 diabetes and obesity owing to their robust metabolic…

A Comparison of Automated Insulin Delivery Systems

Do automated insulin delivery systems outperform systems requiring manual upload and adjustment? Automated insulin delivery (AID) systems…

EMJ Diabetes 13.1 2025

We are delighted to announce the release of the latest EMJ Diabetes journal! Inside this issue, you will find a variety of content…

Patient and physician perspectives on shared decisions in CML

In this new podcast episode, Lisa Machado, a patient advocate diagnosed with CML in 2008 and clinician and CML expert Jeffrey Lipton, sit…

Beyond the Barrier: Understanding Chronic Hand Eczema as a Multifactorial, Heterogeneous Skin Disease

Skin barrier dysfunction is a defining feature of CHE, independent of aetiology. In healthy skin, the barrier effectively protects…

Interview: Catherine Stedman

I love the huge variety in the specialty, including the balance of inpatient and outpatient work, acute and routine endoscopy procedures…

EMJ's latest Dermatology journal

Our new journal is out now – covering all the latest from EADV 2025 and beyond.Inside, discover the president of EADV’s thoughts on…

Treatment of Type 2 Diabetes

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, leading to…

Review of the European Academy of Dermatology and Venereology (EADV) Congress 2025

THIS AUTUMN, Paris, France, hosted the 34ᵗʰ annual European Academy of Dermatology and Venereology (EADV) Congress. For…